Cambridge Investment Research Advisors
MYOV

Cambridge Investment Research Advisors’s Myovant Sciences Ltd. MYOV Stock Holding History

Cambridge Investment Research Advisors’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-34,590
Closed -$430K – 3185
2022
Q2 		$430K Sell
34,590
-965
-3% -$10.6K ﹤0.01% 2075
2022
Q1 		$474K Sell
35,555
-1,200
-3% -$16.1K ﹤0.01% 2149
2021
Q4 		$572K Sell
36,755
-2,250
-6% -$42.9K ﹤0.01% 1995
2021
Q3 		$875K Hold
39,005
– – ﹤0.01% 1642
2021
Q2 		$888K Buy
39,005
+350
+0.9% +$7.36K ﹤0.01% 1617
2021
Q1 		$796K Buy
38,655
+4,165
+12% +$94.8K ﹤0.01% 1594
2020
Q4 		$953K Buy
34,490
+600
+2% +$11.7K 0.01% 1339
2020
Q3 		$476K Sell
33,890
-9,875
-23% -$184K ﹤0.01% 1636
2020
Q2 		$902K Buy
43,765
+19,190
+78% +$261K 0.01% 1183
2020
Q1 		$186K Sell
24,575
-555
-2% -$6.22K ﹤0.01% 1968
2019
Q4 		$390K Buy
25,130
+14,405
+134% +$145K ﹤0.01% 1742
2019
Q3 		$56K Buy
+10,725
New +$79.6K ﹤0.01% 2273

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cambridge Investment Research Advisors's MYOV Position: Q3 2022 in Review

Cambridge Investment Research Advisors sold out of Myovant Sciences Ltd. (MYOV) in Q3 2022, closing a stake of 34,590 shares — an estimated $430K sold.

Cambridge Investment Research Advisors first reported a position in MYOV in Q3 2019 and held it in 12 quarters. The position peaked at $953K in Q4 2020. 98 funds tracked by Wall St. Rank hold MYOV as of Q3 2022.

  • Cambridge Investment Research Advisors reported no remaining Myovant Sciences Ltd. position as of Q3 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 34,590 Myovant Sciences Ltd. shares in Q3 2022, an estimated $430K.
  • Cambridge Investment Research Advisors first reported a position in Myovant Sciences Ltd. in Q3 2019 and held it in 12 quarters.
  • Cambridge Investment Research Advisors's Myovant Sciences Ltd. position peaked at $953K in Q4 2020.
  • 98 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.